1 recruiting, 1 unknown. 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 1 | 1 | Unknown 1 |
Follow Recurrence Tumor: new trials by email Literature Review of Recurrence Tumor trials Research Report on Recurrence Tumor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Combination of Trimipramine and Atezolizumab With Bevacizumab in Patients With Recurrent Glioblastoma: a Phase 2 Trial Trimipramine, Cohort 1: Atezolizumab, Bevacizumab - Glioblastoma, Recurrence Tumor | Phase 2 | Recruiting | Centre Hospitalier Universitaire Vaudois | 59 | 2025-11-03 | 2026-02-13 |
| Immunotherapy for the Treatment of Advanced Solid Tumor TIL, Aldesleukin, Cyclophosphamide - Recurrence Tumor, Metastatic Cancer | Phase 1 / Phase 2 | Unknown | Tongji Hospital | 40 | 2020-04-28 | 2024-08-13 |
Recurrence (2) · Glioblastoma (1) · Neoplasm Metastasis (1)
Disease Attributes (2) · Neoplasms (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Astrocytoma (1) · Glioma (1) · Neoplasms by Histologic Type (1) · Neoplasms, Germ Cell and Embryonal (1) · Neoplasms, Glandular and Epithelial (1) · Neoplasms, Nerve Tissue (1) · Neoplasms, Neuroepithelial (1) · Neoplastic Processes (1) · Neuroectodermal Tumors (1)
Bevacizumab (1) · Cyclophosphamide (1) · Interleukin-2 (1) · Trimipramine (1) · aldesleukin (1) · fludarabine (1)
Centre Hospitalier Universitaire Vaudois (1) · Tongji Hospital (1)
China (1) · Switzerland (1)
Hui Wang, MD (1)